Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Andreas Schneider, Philipp Richard, Philippe Mueller, Christoph Jordi, Mary Yovanoff & Jakob Lange. (2021) User-Centric Approach to Specifying Technical Attributes of Drug Delivery Devices: Empirical Study of Autoinjector-Cap Removal Forces. Patient Preference and Adherence 15, pages 159-168.
Read now
Read now
Mark L. Warren, Meryl Brod, Jonas Håkan-Bloch, Thomas Sparre & Louis B. Chaykin. (2019) Patient-reported outcomes from a randomized, crossover trial comparing a pen injector with insulin degludec versus a pen injector with insulin glargine U100 in patients with type 2 diabetes. Current Medical Research and Opinion 35:9, pages 1623-1629.
Read now
Read now
Andreas Schneider, Harald Kolrep, Christoph Jordi, Philipp Richard, Hanns-Peter Horn & Jakob Lange. (2019) How to prevent medication errors: a multidimensional scaling study to investigate the distinguishability between self-injection platform device variants. Expert Opinion on Drug Delivery 16:8, pages 883-894.
Read now
Read now
Quentin Lohmeyer, Andreas Schneider, Christoph Jordi, Jakob Lange & Mirko Meboldt. (2019) Toward a new age of patient centricity? The application of eye-tracking to the development of connected self-injection systems. Expert Opinion on Drug Delivery 16:2, pages 163-175.
Read now
Read now
Joan Schertz & Hilary Worton. (2018) Nurse evaluation of the redesigned fertility pen injector: a questionnaire-based observational survey. Expert Opinion on Drug Delivery 15:5, pages 435-442.
Read now
Read now
Andreas E. Schneider & Jakob Lange. (2018) Pen devices for self-injection: contrasting measured injection force with users’ perceived ease of injection. Expert Opinion on Drug Delivery 15:2, pages 115-125.
Read now
Read now
Jacob Hyllested-Winge, Thomas Sparre & Line Kynemund Pedersen. (2016) NovoPen Echo® insulin delivery device. Medical Devices: Evidence and Research 9, pages 11-18.
Read now
Read now
Ad A Kaptein. (2013) Transjecting growth hormone: continuous nightmare or controlled nuisance? Evaluation of a new needle-free device. Patient Preference and Adherence 7, pages 703-708.
Read now
Read now
Articles from other publishers (4)
Sudesna Chatterjee, Kamlesh Khunti & Melanie J. Davies. (2019) Achieving Glycaemic Control with Concentrated Insulin in Patients with Type 2 Diabetes. Drugs 79:2, pages 173-186.
Crossref
Crossref
Lalantha Leelarathna, Donna Ashley, Carrie Fidler & Witesh Parekh. (2018) The value of fast-acting insulin aspart compared with insulin aspart for patients with diabetes mellitus treated with bolus insulin from a UK health care system perspective. Therapeutic Advances in Endocrinology and Metabolism 9:7, pages 187-197.
Crossref
Crossref
Ken Fujioka, Thomas Sparre, Lily Yong-Hui Sun, Susanne Krogsgaard & Robert F. Kushner. (2015) Usability of the Novel Liraglutide 3.0 mg Pen Injector Among Overweight or Obese Adult Patients With or Without Prior Injection Experience. Journal of Diabetes Science and Technology 10:1, pages 164-174.
Crossref
Crossref
Athena Philis-Tsimikas, Meryl Brod, Marcus Niemeyer, Ann Marie Ocampo Francisco & Jeffrey Rothman. (2013) Insulin Degludec Once-Daily in Type 2 Diabetes: Simple or Step-Wise Titration (BEGIN: Once Simple Use). Advances in Therapy 30:6, pages 607-622.
Crossref
Crossref